This High-Yield Dividend Portfolio Will Beat the Market

Twenty weeks ago, I invested my cold hard cash into 10 high-yield dividend stocks I believe will beat the market. Let's see the results so far: [...] Over the past month, the S&P rose 2.6%. As the market rose, our portfolio outperformance dropped, moving from outperforming the market by 7 percentage points to beating it by roughly 4.5 percentage points. While outperformance is always good, it should be taken with a grain of salt. We're investing for the long term, and it's only been 20 weeks. I firmly believe the results will bear us out. Movers & shakers Of our stocks, the biggest mover in the portfolio the past month was Bristol-Myers Squibb, which rose 5.38% (after adjusting for the dividend). The main reason for the rise was a June 23 press release announcing that Pfizer (NYSE: PFE) and Bristol-Myers Squibb's atrial fibrillation drug Eliquis met key endpoints in its quest to replace warfarin. If they are ultimately successful, it could mean billions in sales for the pair.... Read more